1. Home
  2. CVGI vs ENLV Comparison

CVGI vs ENLV Comparison

Compare CVGI & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$4.93

Market Cap

167.7M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.66

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
ENLV
Founded
2000
2005
Country
United States
Israel
Employees
6500
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.7M
196.2M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
CVGI
ENLV
Price
$4.93
$0.66
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
378.9K
412.5K
Earning Date
05-05-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
N/A
EPS
0.04
N/A
Revenue
$755,231,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$123.50
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.25
$0.66
52 Week High
$5.88
$2.10

Technical Indicators

Market Signals
Indicator
CVGI
ENLV
Relative Strength Index (RSI) 49.93 35.55
Support Level $1.50 $0.66
Resistance Level $5.84 $1.23
Average True Range (ATR) 0.34 0.07
MACD -0.08 -0.01
Stochastic Oscillator 23.53 1.71

Price Performance

Historical Comparison
CVGI
ENLV

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: